XML 30 R20.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCK-BASED COMPENSATION
 3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
Based on the vesting schedule of the grants of restricted stock units (“RSU” or “RSUs”) and options, stock-based compensation expense for the three months ended March 31, 2024 and 2023 totaled $656,576 and $479,641, respectively.
The Company has adopted the 2021 Omnibus Stock Incentive Plan, as amended (the “Omnibus Incentive Plan”), which provides for the issuance of incentive stock options, grants of RSUs, and stock-based awards to employees, directors, and consultants of the Company to reward and attract employees and compensate the Company’s Board of Directors (the “Board”) and vendors when applicable. The Omnibus Incentive Plan is administered by the Company's Board. Grants of RSUs under the Omnibus Incentive Plan are valued at no less than the market price of the stock on the date of grant. The fair value of the options is calculated using the Black-Scholes pricing model based on the estimated market value of the underlying common stock at the valuation measurement date, the remaining contractual term of the options, risk-free interest rate and expected volatility of the price of the underlying common stock of 100%. There is a moderate degree of subjectivity involved when estimating the value of stock options with the Black-Scholes option pricing model as the assumptions used are moderately judgmental. Grant of RSUs and stock options are sometimes offered as part of an employment offer package, to ensure continuity of service or as a reward for performance. Grants of RSUs and stock options typically require a 1 to 3 year period of continued employment or service performance before the grant of RSUs or stock options vest. No cash flow effects are anticipated for grants of RSUs or stock options.
The following schedule shows grants of RSU activity for the three months ended March 31, 2024:
Number of
Shares
Grants of RSUs unvested as of December 31, 2023580,292
Grants of RSUs298,857
Forfeiture/cancelled(27,159)
Grants of RSUs vested and issued(375,177)
Grants of RSUs unvested as of March 31, 2024476,813

The following table summarizes the vesting time periods of these unvested RSUs:
Number of SharesVesting Time Period
92,911Remainder of 2024
169,5562025
214,3462026
476,813
The following schedule shows stock option activity for the three months ended March 31, 2024.
OPTIONS:Number of Shares Weighted
Average
Remaining
Life (Years) 		Weighted
Average
Exercise
Price
Stock options outstanding as of December 31, 2023501,8294.67$6.81 
Issued—0$— 
Forfeited(39,880)0$6.52 
Exercised—0$— 
Stock options outstanding as of March 31, 2024461,9494.30$6.83 
Stock options exercisable as of March 31, 2024441,9220$6.77 
As of March 31, 2024, the Company has $0 in unrecognized stock-based compensation expense related to these stock options. The aggregate intrinsic value of the options outstanding and exercisable at March 31, 2024 is $0.